Viewing Study NCT03707860


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-03-11 @ 3:41 AM
Study NCT ID: NCT03707860
Status: WITHDRAWN
Last Update Posted: 2022-05-27
First Post: 2018-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Radiation Oncology Mobile Application
Sponsor: King Hussein Cancer Center
Organization:

Study Overview

Official Title: Radiation Oncology Mobile Application: Symptoms Reporting System and Quality Assurance Tool
Status: WITHDRAWN
Status Verified Date: 2022-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: the program couldn't be implemented
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: γ-App
Brief Summary: To develop a novel a mobile phone application (available on Android and IOS) for patients receiving radiation treatment for head and neck cancer. Through this application, patients will get access to their treatment calender, through a system connected with Mosiac database, which provides a timely and precise access to their treatments schedule.

In addition, patients will be able to report their treatment related toxicity in real time fashion, these symptoms will be addressed daily instead of the weekly floor clinic checks.

Furthermore, the radiation oncologist will receive an instant notification through the application, if there is error in patient's treatment (missing field, wrong dose, etc..)
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: